Fondazione Prada

WORKSHOPS

“Preserving the Brain” aims to explore the complexity of scientific research by retracing the stages from identifying therapeutic targets to the different phases in the validation of new therapies to the availability of a drug for the patient. Throughout the three weeks of the exhibition, institutions participating in the project will give a series of online workshops that will be available to the public via streaming on this website. Each meeting will enable the assessment of a specific aspect in the search for new treatments for neurodegenerative diseases.

Watch the live workshops here
Recordings of past events are posted below.


UPCOMING

4 October, 2PM (CEST)

Sleep in neurodegenerative diseases

Hôpital de la Pitié-Salpêtrière, Sorbonne University AP-HP, Neurology Department and Paris Brain Institute, Paris, France

 

Thomas Andrillon
Role of sleep in cognition and fatigue

Anne Laure Dubessy
Multiple sclerosis and sleep

Isabelle Arnulf
Parkinson’s disease and sleep

Géraldine Rauchs
Dementia and sleep


PAST SEASON

19 September, 10AM (UTC-4) | 4 PM (CEST)

Neuroimmunology of Multiple sclerosis

Yale School of Medicine, New Haven, United States

 

David Hafler | moderator
Overview of the Cause of Multiple sclerosis

David Pitt
Astrocyte and the Neuropathology of Multiple sclerosis

Tomokazu Sumida
Loss of Immune regulation in Multiple sclerosis

Erin Longbrake
New Clinical Trials in Multiple sclerosis

20 September, 10AM (UTC-4) | 4PM (CEST)

How Open Science is Changing Personalized Medicine in Neurodegenerative Diseases and Disorders

Montreal Neurological Institute-Hospital, McGill University, Canada

 

Stefano Stifani | moderator
Welcome and introduction

Jason Karamchandani
The C-BIG Platform: A Novel Open Science Combined Patient Registry and Multi-Modal Repository

Tom Durcan
The Neuro’s Early Drug Discovery Unit: Opening up discovery through collaboration and outreach

Jo-Anne Stratton
Open Science in the works: a deeper understanding of Parkinson’s Disease immunology

Sali Farhan
Leveraging Open Science to advance gene discovery in neurodegenerative diseases

Annabel Seyller
Closing remarks

22 September, 1PM (CEST)

Demyelination & remyelination in neurodegeneration: From molecule to clinical application

Karolinska Institutet, Stockholm, Sweden

 

Ole Petter Ottersen
Opening speech

Maja Jagodic
Molecular markers of Multiple Sclerosis development and progression

Tobias Granberg
In vivo imaging and quantification of demyelination and remyelination

Fredrik Piehl, Gonçalo Castelo-Branco, Chiara Starvaggi Cucuzza
Moderators

23 Settembre, 3PM (CEST)

PET molecular imaging in “brain neurodegenerative diseases"

UniSR – Università Vita-Salute San Raffaele, Milan, Italy

 

Daniela Perani | moderator
Introducing and chairing

Rik Ossenkoppele
Assessment of Alzheimer’s disease pathology in the living human brain

Gael Chetelat
Evaluating the brain reserve effect on neurodegeneration

Valentina Garibotto
How artificial intelligence can support our investigation of the brain

26 September, 9AM (CEST)

Multiple Sclerosis: The Gut-Brain Connection

Max Planck Institute of Neurobiology, Munich, Germany

 

Hartmut Wekerle | moderator
Introduction: The gut-brain axis in MS

Naoto Kawakami
Autoimmune T cell traffic gut to brain

Amira Metwaly
Microbiota and human disease

Lisa Gerdes
MS twin study

Anneli Peters
Microbiota and MS – From model to human MS

27 September, 12PM (UTC-4) | 6PM (CEST)

Innate immunity in neurodegenerative diseases

Harvard Medical School, Brigham and Women’s Hospital, Ann Romney Center for Neurological Diseases, Boston, United States

 

Francisco Quintana
Astrocytes

Oleg Butovsky
Microglia

Rafael Machado Rezende
Nasal anti-CD3 treatment of neurodegenerative diseases

Howard Weiner
Protollin treatment of Alzheimer’s disease

27 September, 7.30PM (UTC+9) | 12.30PM (CEST)

Parkinson’s disease from pathophysiology to treatment

Juntendo University Hospital, Neurology Department, Tokyo, Japan

 

Nobutaka Hattori
Two hundred years’ history of Parkinson’s disease

Taku Hatano
The accumulation and propagation of alpha synuclein in synucleinopathies

Shinji Saiki
Novel biomarkers for detection of early Parkinson’s disease and its progression

Taiji Tsunemi | moderators
Small extracellular vescicles matter in the development of Parkinson’s disease

28 September, 9AM (UTC-7) | 6PM (CEST)

Monitoring Neurodegeneration in Multiple Sclerosis

UCSF Weill Institute for Neurosciences, University of California San Francisco, San Francisco, United States

 

Steve Hauser | moderator
Welcome and Introduction

Riley Bove
Visualizing Neurodegeneration in Real-time: A BRIDGE to the Clinic

Valerie Block
Stepping into the Future – Remote Monitoring as a Signal for MS Progression

Roland Henry
Spinal Cord Atrophy Precedes and Predicts Progressive MS and Silent Disability Worsening

Michael Wilson
Antibody Targets in Multiple Sclerosis

Sergio Baranzini
Linking Microbes and Diet to Neurodegeneration and Clinical Outcomes: Massive Data Integration with a Knowledge Graph

Stephen Hauser
Speaker Roundtable Discussion

29 September, 7:30PM (UTC+8) | 1.30PM (CEST)

Neuroimaging in dementia

Tianjin Medical University General Hospital, Neurology Department, Tianjin, China

 

Nan Zhang | moderator
Opening

Qin Chen
Neuroimaging in familial frontotemporal lobar degeneration

Jun Wang
Beijing Aging Brain Rejuvenation Initiative (BABRI): Revealing Neuroimaging Indicators

Mengya Xing
Cerebral blood flow pattern measured with Arterial Spin Labeling in subcortical ischemic vascular dementia

Nan Zhang
Discussion

30 September, 10AM (CEST)

Inflammation and immunological responses in neurodegenerative diseases

German Center for Neurodegenerative Diseases (DZNE) within the Helmholtz Association, Bonn, Germany

 

Adriano Aguzzi
Lessons learned from prion diseases

Michael Heneka
Sterile inflammation in neurodegenerative disease

Harald Pruess
Anti-neuronal autoantibodies in neurodegenerative dementia